Procter & Gamble (NYSE:PG) Stock Price Up 1.4% – Still a Buy?

Procter & Gamble Company (The) (NYSE:PGGet Free Report) shares shot up 1.4% on Friday . The company traded as high as $143.11 and last traded at $142.77. 9,565,137 shares changed hands during mid-day trading, an increase of 17% from the average session volume of 8,180,575 shares. The stock had previously closed at $140.76.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on PG shares. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Morgan Stanley set a $175.00 price target on Procter & Gamble in a report on Monday, October 27th. JPMorgan Chase & Co. increased their price target on Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Deutsche Bank Aktiengesellschaft cut their price objective on Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research report on Monday. Finally, BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $171.40.

View Our Latest Analysis on Procter & Gamble

Procter & Gamble Trading Up 1.4%

The company has a market capitalization of $333.61 billion, a PE ratio of 20.84, a price-to-earnings-growth ratio of 4.70 and a beta of 0.39. The company has a 50 day simple moving average of $148.03 and a 200 day simple moving average of $154.50. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period in the previous year, the company posted $1.93 earnings per share. The business’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.75%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 4,252 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the transaction, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at $8,219,202.16. This trade represents a 7.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 30,308 shares of company stock valued at $4,611,852. Company insiders own 0.20% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of institutional investors have recently added to or reduced their stakes in the stock. Halbert Hargrove Global Advisors LLC acquired a new stake in Procter & Gamble during the third quarter worth about $25,000. Nova Wealth Management Inc. acquired a new position in Procter & Gamble in the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC grew its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after buying an additional 72 shares during the period. Saranac Partners Ltd acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $30,000. Finally, Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at approximately $32,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.